Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty, SI joint fusion.
All companies · Product and company coverage
In 2025, L&K Biomed reported engagement with 6 surgeons and other clinicians in the states MedaRep covers, worth $146K in consulting, speaking, meals and travel for its device products, the most in Michigan ($80K to 1). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Michigan ($80K, 1 engaged), California ($39K, 2 engaged), Arizona ($20K, 1 engaged), Virginia ($5,293, 1 engaged), North Carolina ($1,619, 1 engaged).
In the last ten years FDA made 34 decisions for L&K Biomed (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2023 (8). The latest was on 2026-08-18.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 42 |
| Cervical fusion & disc arthroplasty | 18 |
| SI joint fusion | 4 |
| CastleLoc Pectus Bar System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to L&K Biomed.